Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medivolve Inc. Board/Management Information 2023

Nov 15, 2023

45925_rns_2023-11-14_5bffb562-f083-4d04-b6e4-d928c0e84fcc.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

FORM 51-102F3 MATERIAL CHANGE REPORT

Item 1 Name and Address of Company

Medivolve Inc. (“ Medivolve ” or the “ Company ”) 198 Davenport Road Toronto, Ontario M5R 1J2

Item 2 Date of Material Change

November 6, 2023

Item 3 News Release

A news release was issued by Medivolve through the facilities of GlobeNewswire on November 6, 2023 and was subsequently filed on SEDAR.

Item 4 Summary of Material Change

Dr. Beverley Richardson resigned from the board of directors of the Company, effective immediately.

Item 5 Full Description of Material Change

The Company announced that Dr. Beverley Richardson resigned from its board of directors, effective immediately.

Item 6 Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7 Omitted Information

Not applicable.

Item 8 Executive Officer

Aaron Atin Corporate Secretary (416) 861-5888

Item 9 Date of Report

November 14, 2023